Literature DB >> 32335593

Distribution of Hemoglobinopathy in Nepalese Population.

Rekha Manandhar Shrestha1, Roshan Pandit1, Udaya Kumar Yadav1, Rameshwar Das1, Binod Kumar Yadav2, Harish Chandra Upreti1.   

Abstract

BACKGROUND: Sickle cell and thalassemia are the inherited disorders of globin chain synthesis, and are the most common monogenic disease worldwide. This study aims to find the distribution of hemoglobinopathies (sickle cell and thalassemia) cases in Nepal using laboratory based data.
METHODS: A retrospective study was carried out at five different sites of Nepal Government that uses capillary electrophoresis for screening of hemoglobin disorders from January 2019 to March 2019. All the cases diagnosed positive for hemoglobinopathy till December 2018 were collected from laboratory record at each sites, and analyzed using Statistical Package for Social Sciences (SPSS version 20.0).
RESULTS: Out of total 4018 patients tested during the period in all five different sites, 1470 were diagnosed positive for hemoglobinopathy. Sickling disorder was the most predominant hemoglobinopathy followed by ?-thalassemia. Province 5, province 6 and province 7 were mostly affected by sickling disorder while the other provinces by ?-thalassemia.
CONCLUSIONS: Sickle cell is the commonest cause of hemoglobinopathy followed by B thallesmias in Nepalese population. Sickle cell is more concentrated towards western part of Nepal and especially in Tharu ethnic population. In contrast, the distribution of ?-thalassemia is found throughout the country and among all ethnic groups of population.

Entities:  

Keywords:  Hemoglobinopathy; Nepal; sickle cell; thalassemia.

Year:  2020        PMID: 32335593     DOI: 10.33314/jnhrc.v18i1.2303

Source DB:  PubMed          Journal:  J Nepal Health Res Counc        ISSN: 1727-5482


  3 in total

1.  Can HPLC be used as an ideal methodology instead of Hb Electrophoresis for the diagnosis of hemoglobinopathies in a routine clinical laboratory of under-resource country like Nepal? Is the change necessary?

Authors:  Amrit Bhusal; Silan Bhandari; Rajesh Prasad Sah
Journal:  Ann Med Surg (Lond)       Date:  2022-08-18

Review 2.  Hydroxyurea and blood transfusion therapy for Sickle cell disease in South Asia: inconsistent treatment of a neglected disease.

Authors:  Thamal Darshana; David Rees; Anuja Premawardhena
Journal:  Orphanet J Rare Dis       Date:  2021-03-23       Impact factor: 4.123

3.  Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries.

Authors:  Bin Hashim Halim-Fikri; Carsten W Lederer; Atif Amin Baig; Siti Nor Assyuhada Mat-Ghani; Sharifah-Nany Rahayu-Karmilla Syed-Hassan; Wardah Yusof; Diana Abdul Rashid; Nurul Fatihah Azman; Suthat Fucharoen; Ramdan Panigoro; Catherine Lynn T Silao; Vip Viprakasit; Norunaluwar Jalil; Norafiza Mohd Yasin; Rosnah Bahar; Veena Selvaratnam; Norsarwany Mohamad; Nik Norliza Nik Hassan; Ezalia Esa; Amanda Krause; Helen Robinson; Julia Hasler; Coralea Stephanou; Raja-Zahratul-Azma Raja-Sabudin; Jacques Elion; Ghada El-Kamah; Domenico Coviello; Narazah Yusoff; Zarina Abdul Latiff; Chris Arnold; John Burn; Petros Kountouris; Marina Kleanthous; Raj Ramesar; Bin Alwi Zilfalil
Journal:  J Pers Med       Date:  2022-03-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.